Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-12-15 | Catherine M. Burzik, 66, has been a director since 2013. From 2006 until the sale of the company in 2012, she served as President and Chief Executive Officer of Kinetic Concepts, Inc., a medical device company specializing in the fields of wound care and regenerative medicine. Prior thereto, she was President of Applied Biosystems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. Ms. Burzik also is a director of Haemonetics Corporation and General Partner of Targeted Technology Fund II, LP. She was formerly a director of Allscripts Healthcare Solutions, Inc. Ms. Burzik is a seasoned executive in the healthcare industry, having led major medical device, diagnostic, diagnostic imaging and life sciences businesses. She contributes strong strategic and leadership expertise, and extensive knowledge of the global healthcare field. The Audit Committee members include Bertram L. Scott–Chair, Basil L. Anderson, Catherine M. Burzik, Christopher Jones, Willard J. Overlock, Jr., Rebecca W. Rimel. The Science, Marketing, Innovation and Technology Committee members include Claire M. Fraser–Chair, Catherine M. Burzik, R. Andrew Eckert, Christopher Jones, Willard J. Overlock, Jr., Claire Pomeroy, Rebecca W. Rimel. The Fiscal Year 2016 Non-Management Directors’ Compensation table shows Catherine M. Burzik with total compensation of $281,361. |
| 2017-12-14 | Catherine M. Burzik, 67, has been a director since 2013. ... Ms. Burzik also is a director of Haemonetics Corporation. ... Ms. Burzik is a seasoned executive in the healthcare industry ... Audit Committee member ... Science, Marketing, Innovation and Technology Committee member ... Fiscal Year 2017 Non-Management Directors' Compensation: Total $301,611. |
| 2018-12-03 | Catherine M. Burzik, 68, has been a director since 2013. ... Ms. Burzik is a seasoned executive in the healthcare industry... The Audit Committee members include Bertram L. Scott—Chair, R. Andrew Eckert, Jeffrey W. Henderson, David F. Melcher, Willard J. Overlock, Jr., Rebecca W. Rimel. The Board has determined that each of Ms. Burzik and Messrs. Henderson, Melcher and Scott qualifies as an “audit committee financial expert”... Corporate Governance and Nominating Committee members include Gary A. Mecklenburg—Chair, Catherine M. Burzik, Claire M. Fraser, Christopher Jones, Marshall O. Larsen, Claire Pomeroy... Quality and Regulatory Compliance Committee members include Catherine M. Burzik—Chair, Claire M. Fraser, Christopher Jones, Marshall O. Larsen, Gary A. Mecklenburg, Claire Pomeroy, Timothy M. Ring... Science, Marketing, Innovation and Technology Committee members include Claire M. Fraser—Chair, Catherine M. Burzik, R. Andrew Eckert, Willard J. Overlock, Jr., Claire Pomeroy, Rebecca W. Rimel, Timothy M. Ring... Fiscal Year 2018 Non-Management Directors’ Compensation table shows Catherine M. Burzik total compensation as $344,249. |
| 2020-12-17 | Catherine M. Burzik, 70, has been a director since 2013. ... Ms. Burzik is a seasoned executive in the healthcare industry... Committee memberships: Corporate Governance and Nominating Committee, Quality and Regulatory Committee, Science, Marketing, Innovation and Technology Committee. Fiscal Year 2020 Non-Management Directors’ Compensation: $347,072. |
| 2021-12-16 | Catherine M. Burzik | 71Former President and Chief Executive Officer, Kinetic Concepts, Inc. Director Since:2013 Independent:Yes Committees: Quality and Regulatory (Chair), Corporate Governance and Nominating, Science, Marketing, Innovation and Technology. Non-management director compensation table shows total compensation of $351,172. |
| 2022-12-15 | Catherine M. Burzik | 72Former President and Chief Executive Officer, Kinetic Concepts, Inc...Independent:Yes...Committees: Quality and Regulatory (Chair), Corporate Governance and Nominating...Fiscal 2022 director compensation: Catherine M. Burzik 348,580 |
| 2023-12-14 | Catherine M. Burzik | 73 Former President and Chief Executive Officer, Kinetic Concepts, Inc. Director Since: 2013 Independent: Yes Committees: Quality and Regulatory (Chair), Corporate Governance and Nominating Fiscal 2023 director compensation: Total 357,778 |
| 2024-12-19 | Ms. Burzik is a seasoned executive in the healthcare industry, having led major medical device, diagnostic, diagnostic imaging and life sciences businesses. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-06-12 | Ms. Burzik, 66, joined the Board of Directors in 2016 and is a member of the Audit Committee. Compensation for the Board of Directors in fiscal 2017 was $205,989 for Ms. Burzik. |
| 2018-06-12 | Catherine M. Burzik President and CEO, CFB Interests, LLC; Former President and CEO, Kinetic Concepts, Inc. Age: 67 Ms. Burzik joined our Board in 2016 and is a member of both the Audit Committee and the Governance and Compliance Committee. DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR ENDED MARCH 31, 2018 Catherine M. Burzik Fees Earned or Paid in Cash ($): 77,000 Stock Awards ($): 170,000 Total ($): 247,000 |
| 2019-06-12 | Catherine M. Burzik President and CEO, CFB Interests, LLC; Former President and CEO, Kinetic Concepts, Inc. Age: 68. Ms. Burzik joined our Board in 2016 and is the Chair of the Technology Committee and a member of the Audit Committee. Director Compensation Table for Fiscal Year Ended March 30, 2019 shows total compensation of $254,800. |
| 2020-06-08 | Catherine M. Burzik President and CEO, CFB Interests, LLC; Former President and CEO, Kinetic Concepts, Inc. Age: 69 Ms. Burzik joined our Board in 2016 and is the Chair of the Technology Committee and a member of the Audit Committee. Ms. Burzik is currently President and Chief Executive Officer of CFB Interests, LLC. From 2013 to 2017, Ms. Burzik was also a general partner at Targeted Technology, an early stage venture capital firm focused on medical device, life sciences and biotech investments. Ms. Burzik previously served as President and Chief Executive Officer of Kinetic Concepts, Inc., a leading medical device company specializing in the fields of wound care and regenerative medicine, from 2006 until the Company’s sale in 2012. Prior to joining Kinetic Concepts, Inc., Ms. Burzik’s leadership experience included serving as President of Applied Biosystems and holding senior executive positions at Eastman Kodak and Johnson & Johnson, including Chief Executive Officer and President of Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. In addition to her public company board service, Ms. Burzik is a member of the Board of Directors of Xenex Disinfection Services, LLC and is Chairperson of the Boards of Directors of the American College of Wound Healing and Tissue Repair, Gemini Bio-Products, Inc. and StemBioSys, Inc. |
| 2021-06-17 | Ms. Burzik joined our Board in 2016 and is the Chair of the Technology Committee and a member of the Audit Committee. Ms. Burzik is currently President and Chief Executive Officer of CFB Interests, LLC. From 2013 to 2017, Ms. Burzik was also a general partner at Targeted Technology, an early stage venture capital firm focused on medical device, life sciences and biotech investments. Ms. Burzik previously served as President and Chief Executive Officer of Kinetic Concepts, Inc., a leading medical device company specializing in the fields of wound care and regenerative medicine, from 2006 until the Company’s sale in 2012. Prior to joining Kinetic Concepts, Inc., Ms. Burzik’s leadership experience included serving as President of Applied Biosystems and holding senior executive positions at Eastman Kodak and Johnson & Johnson, including Chief Executive Officer and President of Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. In addition to her public company board service, Ms. Burzik is a member of the Board of Directors of Xenex Disinfection Services, LLC and is Chairperson of the Boards of Directors of the American College of Wound Healing and Tissue Repair, Gemini Bio-Products, Inc. and StemBioSys, Inc. |
| 2022-06-17 | Catherine M. Burzik Former President and Chief Executive Officer, Kinetic Concepts, Inc. Age: 71 Ms. Burzik joined our Board in October 2016 and is the Chair of the Technology Committee and a member of the Audit Committee. Ms. Burzik is currently President and Chief Executive Officer of CFB Interests, LLC. From 2013 to 2017, Ms. Burzik was also a general partner at Targeted Technology, an early stage venture capital firm focused on medical device, life sciences and biotechnology investments. Ms. Burzik previously served as President and Chief Executive Officer of Kinetic Concepts, Inc., a leading medical device company specializing in the fields of wound care and regenerative medicine, from 2006 until the Company’s sale in 2012. Prior to joining Kinetic Concepts, Inc., Ms. Burzik’s leadership experience included serving as President of Applied Biosystems and holding senior executive positions at Eastman Kodak and Johnson & Johnson, including Chief Executive Officer and President of Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. In 2019, Ms. Burzik received the AdvaMed Lifetime Achievement Award that honors accomplishments of pioneers in the medical technology industry. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-29 | Catherine M. Burzik New Director Nominee (Expected to be Appointed Chair of the Board if Elected as a Director at the Annual Meeting) Ms. Burzik, 70, has been nominated by the Board to become a director as of the Annual Meeting. If elected as a director by the Company’s shareholders, it is the Board’s intent that she will be appointed as Chair of the Board. The following table provides information regarding the 2020 compensation of non-employee directors. Catherine M. Burzik No compensation listed as she is a new nominee. |
| 2022-04-27 | Ms. Burzik, 71, was appointed to the Board in June 2021. She currently serves as Chair of the Board. The following table provides information regarding the 2021 compensation of non-employee directors. Catherine M. Burzik received total compensation of $580,658. |
| 2023-04-27 | Catherine M. Burzik Lead Independent Director Age 72 Audit & Finance Committee member 2022 compensation: $380,002 |
Data sourced from SEC filings. Last updated: 2026-02-03